...
首页> 外文期刊>Pharmaceutical development and technology >The influence of surfactants and additives on drug release from a cationic eudragit coated multiparticulate diltiazem formulation.
【24h】

The influence of surfactants and additives on drug release from a cationic eudragit coated multiparticulate diltiazem formulation.

机译:表面活性剂和添加剂对阳离子Eudragit包被的多地尔硫卓制剂释放药物的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

A cationic polymethacrylate coated multiparticulate diltiazem formulation exhibited sigmoidal drug release. Lag time prior to drug release was influenced by dissolution media, coat thickness, and by the nature of additives included in the formulation. Incorporation of up to 5% w/w sodium lauryl sulfate (SLS) in the coating membrane resulted in substantial increases in lag times in acidic and neutral media. The extent of drug release in acid was 100%, whereas in phosphate buffer, the extent of release was dependent on the level of SLS. Substituting SLS for various compounds was used to assess the functionality of the SLS molecule responsible for these behaviors. The ability to ion-pair with the polymer and the presence of a hydrophobic moiety were both important functionalities.
机译:阳离子聚甲基丙烯酸酯涂层的多地尔硫卓制剂显示出乙状药物释放。药物释放前的滞后时间受溶出介质,包衣厚度和制剂中所含添加剂的性质的影响。在涂膜中掺入高达5%w / w的十二烷基硫酸钠(SLS),导致在酸性和中性介质中的滞后时间大大增加。酸中药物释放的程度为100%,而在磷酸盐缓冲液中,释放程度取决于SLS的水平。用SLS替代各种化合物可评估引起这些行为的SLS分子的功能。与聚合物离子配对的能力和疏水部分的存在都是重要的功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号